OTC Financial Network Issues Corporate Profile on Wound Management Technologies, Inc.

FORT WORTH, TX--(Marketwire - February 19, 2009) - Wound Management Technologies, Inc. (OTCBB: WNDM) announced today that OTC Financial Network (OTCFN), a division of National Financial Communications Corp., has issued a corporate profile on the Company. Wholly owned subsidiary Wound Care Innovations, LLC (WCI) owns the exclusive worldwide rights to market a patented FDA cleared wound care product line branded under the name CellerateRx®. The OTC report details the CellerateRx® technology platform, multiple health care applications and opportunities for international expansion. Interested parties can download the report at http://www.otcfn.com/wndm/wndm-report.pdf or call Jamie Dryer at 561-837-8057 ext. 2 for additional information.

Geoffrey Eiten, publisher of the OTCFN Report, said, "The advanced wound care market is one of the fastest growing niche segments serving the increased global need for better, more affordable health care. An aging population and increased prevalence of diabetes worldwide are driving up the incidences of chronic pressure ulcers, hard-to-heal wounds and diabetic foot ulcers. Globally, the World Health Organization (WHO) estimates that more than 180 million people have diabetes, and that this number is likely to more than double by 2030. The patented Activated Collagen used in CellerateRx® has been clinically shown in patients to help advance the management of diabetic foot ulcers and improve the healing process of all types of acute and chronic wounds, including first and second degree burns, and post surgical wounds."

Eiten continued, "In the U.S., CellerateRx® is currently sold to podiatrists and other physicians, hospitals, in-home care providers, health care facilities, medical distributors and direct-to-consumers over the internet. Major international companies in the biotech and pharmaceutical industry are also beginning to take notice. WCI has entered into discussions overseas and anticipates to announce new global partnerships throughout 2009. As Wound Management Technologies continues on an exciting path of domestic and international growth, the Company has the potential to significantly increase shareholder value in 2009 and beyond."

About OTC Financial Network

Since 1992, OTC Financial Network has carved its niche as the nation's leading small/micro-cap investor relations and financial communications firm. For information, please visit http://www.otcfn.com. OTC Financial Network is a division of National Financial Communications Corp. (http://www.nationalfc.com) based in Needham, MA.

OTC Financial Network serves as special advisor to Wound Management Technologies, Inc. and has received fees for services, including a monthly retainer of five thousand dollars, for the creation and distribution of material, including the OTCFN report. This is not an offer to buy or sell securities. Information or opinions in this release and the report mentioned herein are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. A full disclaimer can be found online by visiting http://www.otcfn.com/wndm/disclaimer.html.

About Wound Management Technologies, Inc.

Wound Management Technologies, Inc. (WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company's products, please visit www.Celleraterx.com.

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.